Pulike Biological Engineering, Inc.
SHH: 603566.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Wei Hu
- Employees
- 1,679
- Headquarters
- Luoyang, China
- IPO year
- 2015
- Market cap
- CN¥4.0B
- Website
- https://en.pulike.com.cn
Loading 603566…
Loading profile data…Frequently asked questions about 603566
What does Pulike Biological Engineering, Inc. (603566.SS) do?
Pulike Biological Engineering, Inc. engages in the research and development, production, and marketing of veterinary biological products and drugs. It offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. The company is headquartered in Luoyang, China.
Where does 603566.SS trade?
Pulike Biological Engineering, Inc. (603566.SS) trades on the Shanghai Stock Exchange.
What sector is 603566.SS in?
Pulike Biological Engineering, Inc. (603566.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pulike Biological Engineering, Inc.?
Wei Hu is the chief executive officer of Pulike Biological Engineering, Inc. (603566.SS).
Where is Pulike Biological Engineering, Inc. headquartered?
Pulike Biological Engineering, Inc. is headquartered in China.
Does 603566.SS pay a dividend?
Yes — Pulike Biological Engineering, Inc. (603566.SS) paid a trailing twelve-month dividend of CNY 0.60 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603566.SS go public?
Pulike Biological Engineering, Inc. (603566.SS) completed its initial public offering in 2015.